Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 14, 2013 - Issue 16
Submit an article Journal homepage
609
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluations

Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?

Vivencio BarriosHospital Ramon y Cajal, Department of Cardiology, Madrid 28034, Spain+34 91 336 8665; [email protected]@salud.madrid.org
, MD PhD &
Carlos EscobarHospital La Paz, Department of Cardiology, Madrid, Spain
, MD PhD
Pages 2249-2261 | Published online: 26 Sep 2013

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vivencio Barrios & Carlos Escobar. (2014) Which thiazide to choose as add-on therapy for hypertension?. Integrated Blood Pressure Control 7, pages 35-47.
Read now

Articles from other publishers (4)

Marie Hjermitslev, Daniela G. Grimm, Markus Wehland, Ulf Simonsen & Marcus Krüger. (2017) Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension. Basic & Clinical Pharmacology & Toxicology 121:4, pages 225-233.
Crossref
M. Peng, S. Li, J. Wu, Y. Guo, S. Cao & Y. Zhao. (2017) Fragmentation studies of sartans by electrospray ionization mass spectrometry. Journal of Mass Spectrometry 52:9, pages 591-596.
Crossref
Santosh Kumar Puttrevu, Rachumallu Ramakrishna, Manisha Bhateria, Moon Jain, Kashif Hanif & Rabi Sankar Bhatta. (2017) Pharmacokinetic-pharmacodynamic modeling of the antihypertensive interaction between azilsartan medoxomil and chlorthalidone in spontaneously hypertensive rats. Naunyn-Schmiedeberg's Archives of Pharmacology 390:5, pages 457-470.
Crossref
Anselm K. Gitt, Peter Bramlage, Sebastian A. Potthoff, Peter Baumgart, Felix Mahfoud, Hartmut Buhck, Martina Ehmen, Taoufik Ouarrak, Jochen Senges & Roland E. Schmieder. (2016) Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry. BMC Cardiovascular Disorders 16:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.